Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Nov 16.
Published in final edited form as: J Am Chem Soc. 2011 Oct 21;133(45):18022–18025. doi: 10.1021/ja2051099

C–H Bond Activation at Palladium(IV) Centers

Joy M Racowski 1, Nicholas D Ball 1, Melanie S Sanford 1,
PMCID: PMC3233235  NIHMSID: NIHMS334021  PMID: 22017502

Abstract

This communication describes the first observation and study of C–H activation at a PdIV center. This transformation was achieved by designing model complexes in which the rate of reductive elimination is slowed relative to that of the desired C–H activation process. Remarkably, the C–H activation reaction can proceed under mild conditions and with complementary site selectivity to analogous transformations at PdII. These results provide a platform for incorporating this new reaction as a step in catalytic processes.


Over the past decade, high oxidation state palladium catalysis has found increasingly diverse applications in organic synthesis.1 The development of new transformations in this area has been guided by fundamental studies of PdIII and PdIV model complexes, which have provided key insights into the unique reactivity and mechanisms accessible at high valent palladium centers.1,2 To date, these model studies have focused primarily on reductive elimination from PdIII and/or PdIV species.1,2 In contrast, the possibility of other organometallic transformations at high oxidation state Pd has not been explored in detail. This is likely due to the assumption that reductive elimination occurs much faster than competing reactions.

Very recently, several groups have proposed a new reaction – C–H activation at a transient PdIV intermediate – as a key step in catalysis.37 This novel mode of reactivity has been implicated in four different catalytic contexts: (i) C–H oxidative coupling reactions,3 (ii) the carboamination of olefins,4 (iii) the acetoxylation of allylic C–H bonds,5 and (iv) the C–H arylation of naphthalene.6,7 Remarkably, many of these catalytic reactions proceed under unusually mild conditions35 and/or exhibit unprecedented site selectivities.3,4,6 These results suggest that harnessing C–H activation at PdIV could provide opportunities for achieving distinct and complementary reactivity relative to analogous (and much more common) transformations at PdII centers.

While the reports described above have proposed C–H activation at PdIV during catalysis, there is currently no literature precedent for such a transformation. As such, we sought to design model systems to demonstrate the viability of this reaction and to probe reactivity and site selectivity in this context.8,9 This communication demonstrates that, with appropriate choice of supporting ligands, C–H activation at a PdIV center can proceed rapidly at room temperature. Furthermore, we show that the site selectivity of this transformation can be dramatically different than that at analogous PdII complexes. These results provide a platform for incorporating this reaction as a step in new catalytic processes.

In order to observe and study C–H activation at PdIV, it is critical to slow competing C–X bond-forming reductive elimination (kRE) while increasing the relative rate of the desired C–H activation process (kC–H) (Scheme 1). On the basis of these considerations, we initiated investigations of oxidatively-induced C–H activation at complex 1 (Scheme 2). This PdII starting material contains a rigid bidentate sp2 N-donor ligand [2,2’-bis(4-tert-butylbipyridine (dtbpy)] and a chloride. Both of these ligands are known to slow reductive elimination (kRE) from high valent Pd intermediates,1113 often enabling detection/isolation of PdIII or PdIV species.1,2,1113 In addition, the tethered aryl C–H bond could undergo sp2 C–H activation to afford a 5-membered palladacycle. The intramolecular nature of this C–H cleavage event is expected to increase kC–H.10

Scheme 1.

Scheme 1

Competing Reductive Elimination versus C–H Activation at PdIV

Scheme 2.

Scheme 2

Oxidation of 1 with PhCl2: Formation of 2 and 3 (N~N = dtbpy)

We first examined the oxidation of 1 with PhICl2, since this reagent is known to react with PdII starting materials to yield isolable PdIV products.13 As shown in Scheme 2, the reaction produced two major inorganic compounds: PdIICl2(2, 83% yield) and complex 3 (16% yield). Both 2 and 3 are PdII species rather than the desired PdIV products; however, 3 is remarkable in that it contains a σ-aryl rather than a σ-alkyl ligand bound to Pd. We hypothesized that 2 and 3 might be formed from transient PdIV intermediate I, which could undergo competing sp3-C–Cl bond-forming reductive elimination (to liberate 2) and C–H activation/sp3-C–Cl bond-formation to generate 3. While these were promising initial results, complex 3 remained a minor side product under all conditions examined. Additionally, efforts to observe PdIV intermediates I and/or II were unsuccessful in this system.

The results in Scheme 2 suggest that kRE is significantly faster than kC–H for intermediate I. We reasoned that this problem could be addressed by: (1) replacing the chloride with an X-type ligand that is less prone to reductive elimination and (2) limiting the conformational flexibility of the tethered C–H substrate. As such, we next targeted PdII(CF3)(2-PhC6H4)(dtbpy) (4) as our PdII starting material. The incorporation of the CF3 ligand was a particularly important design feature, since several recent reports have shown that PdIV(CF3)(Aryl) complexes can be stable to reductive elimination at or above room temperature.14 Complex 4 was prepared in 58% yield by the reaction of PdII(I)(2-PhC6H4)(dtbpy) with CsF/TMSCF3 in THF.

The treatment of 4 with 1 equiv of PhICl2 in MeCN at 25 °C for 35 min resulted in a color change from pale yellow to dark yellow along with the formation of products 5-Cl, 6, and 7 in 81%, 12%, and 11% yield as determined by 1H NMR spectroscopic analysis of the crude reaction mixture (eq. 1). Complex 5-Cl was isolated in 77% yield by recrystallization from CH2Cl2/Et2O. Characterization of 5-Cl by NMR spectroscopy, mass spectrometry, and X-ray crystallography (of a close analogue, vide infra) revealed that this is an octahedral PdIV complex containing a cyclometalated biphenyl ligand. This indicates that the desired C–H activation event has occurred.

graphic file with name nihms334021f7.jpg (1)

In order to gain insights into the mechanism of the C–H activation process, we monitored the reaction of 4 with d5-PhICl2 at −30 °C in CD3CN (Scheme 3). 1H and 19F NMR analysis showed fast consumption of starting material, and the formation of a transient intermediate 8.15 Upon warming to RT, this intermediate decayed over 35 min with 1st order kinetics to form a mixture of 5-Cl and 6 (final ratio of 5-Cl : 6 = 1.0 : 0.27 under these conditions). Intermediate 8 shows resonances associated with 15 aromatic protons, and a 1H-1H COSY allowed assignment of five distinct protons on the pendant phenyl ring.16 This indicates that this ring is not yet cyclometalated (and also shows that rotation about the aryl-aryl bond is slow on the NMR timescale). 19F-13C HMBC further confirmed that 8 contains a single σ-aryl ligand, as the CF3 fluorines showed only one correlation with an aromatic carbon. In contrast, two 19F-13C HBMC correlations were observed for the cyclometalated product 5-Cl. Finally, a DOSY experiment showed that 5-Cl and 8 have nearly identical diffusion coefficients at −15 °C, indicating that these complexes have similar hydrodynamic radii. This is consistent with the formulation of 8 as a monomeric octahedral complex.

Scheme 3.

Scheme 3

Low temperature NMR study of reaction of 4 with d5-PhICl2

Mass spectrometry experiments provided further insights into the molecular structure of 8. ESI-MS showed a peak at 631.1312, which corresponds to the mass of [Pd(CF3)(2-PhC6H4)(Cl)(dtbpy)]+. Notably, electrospray ionization commonly results in loss of one X-type ligand from PdIV complexes.2g For example, ESI-MS of 5-Cl affords a peak at 595.1560, corresponding to the mass of [5-Cl–Cl]+. MALDI, a softer ionization technique, resulted in a peak at 667.1, which corresponds to [Pd(CF3)(2-PhC6H4)(Cl)2(dtbpy)+H]+.

All of the NMR and MS data presented above are consistent with formulation of intermediate 8 as a PdIV complex of general structure PdIV(CF3)(2-PhC6H4)(Cl)2(dtbpy). The diamagnetic nature of this complex clearly indicates that it is not a monomeric PdIII species. The NMR diffusion experiment along with MALDI MS data provide evidence against alternative formulations as a PdIII dimer or a square planar PdII complex.17 Overall, the characterization data are fully consistent with the C–H activation event occurring at PdIV intermediate 8, thereby representing the first demonstration that high oxidation state Pd can mediate this transformation.

We next explored the reaction of 4 with other 2e oxidants. While no reaction was observed with iodobenzene diacetate (PhI(OAc)2, Table 1, entry 3),2g both iodobenzene bistrifluoroacetate PhI(TFA)2 and N-fluoro-2,4,6-trimethylpyridinium triflate (NFTPT)14 reacted with 4 within 10 min at rt to afford cyclometalated PdIV complexes where X = trifluoroacetate and triflate (5-TFA and 5-OTf, respectively). The structure of the trifluoroacetate complex was confirmed by X-ray crystallography, and an ORTEP picture of 5-TFA is shown in Figure 1. Consistent with the solution NMR data, the crystal structure shows an unsymmetrical ligand environment around the octahedral PdIV center, with the trifluoroacetate group trans to one σ-aryl ligand and the trifluoromethyl group trans to one N of the dtbpy (Figure 1).

Table 1.

Variation of Oxidant (N~N = dtbpy)

graphic file with name nihms334021t1.jpg

Entry Oxidant X (Product) Yield (%)
1 PhICl2 Cl (5-Cl) 77
2 PhI(TFA)2 TFA (5-TFA) 73
3 PhI(OAc)2 OAc (5-OAc) nr[a]
4 NFTPT OTf (5-OTf) 86
[a]

No reaction observed after 12 h at 25 °C.

Figure 1.

Figure 1

ORTEP Plot of 5-TFA

Substrate 9 was also examined in order to probe the accessibility of a six-membered palladacycle (eq. 2). In this case, reaction with PhICl2 for 10 min at 25 °C returned the ortho-chlorinated PdII product 10 in 95% yield. This result suggests that a 6-membered palladacycle was generated, but that the resulting PdIV intermediate underwent rapid C–Cl bond-forming reductive elimination under the reaction conditions.18

graphic file with name nihms334021f8.jpg (2)

Finally, we conducted a series of experiments to compare this C–H activation at PdIV to analogous transformations at PdII centers. A σ-aryl ligand derived from 2-iodo-3,5’-dimethyl-1,1’-biphenyl (ligand abbreviated σ-DMB) was used, since it contains two sterically and electronically differentiated sites for C–H activation (HA and HB). As shown in Scheme 4, the treatment of σ-DMB complex 11 with NFTPT at rt in MeCN produced a 1.7 : 1 mixture of two isomeric products 12-OTf and 13-OTf in 64% yield.19,20 While 12-OTf/13-OTf could not be completely separated, the mixture was characterized using a variety of two-dimensional NMR experiments (see supporting information for details). In addition, treatment of 12-OTf/13-OTf with NaCl afforded the corresponding chloride complexes (12-Cl/13-Cl), and the structure of the major isomer was definitively established by X-ray crystallography. As shown in Figure 2, the X-ray structure confirms that 12-Cl (and by analogy 12-OTf) is the product of C–H activation at HA.

Scheme 4.

Scheme 4

Site Selectivity of C–H Activation at PdIV

Figure 2.

Figure 2

ORTEP Plot of 12-Cl

For comparison, we examined an analogous cyclopalladation reaction at the PdII σ-DMB complex 14-F (eq. 3), which was generated in situ by the treatment of 14-I with AgF. Cyclopalladation at 14-F was sluggish at room temperature and required heating to 60 °C in benzene for 4 h to proceed to completion. Furthermore, this reaction afforded >10 : 1 selectivity for activation of the less sterically hindered C–H bond (HA).21 This selectivity is similar to that observed in numerous other cyclopalladation reactions at PdII centers, but very different from that observed in Scheme 4 (1.7 : 1).22 The significant difference in both rate and selectivity for this C–H activation at PdII versus PdIV highlights the dissimilarity of these processes, and highlights the potential value of PdIV-mediated C–H activation in catalysis.

graphic file with name nihms334021f9.jpg (3)

In summary, this communication describes the first observation and study of C–H activation at PdIV. This transformation was achieved by designing model complexes in which the rate of reductive elimination is slowed relative to that of the desired competing C–H activation process. Remarkably, the C–H activation reaction can proceed under mild conditions and with different site selectivity than analogous transformations at PdII. Investigations are underway to elucidate the mechanism of C–H activation at PdIV and to identify further intra- and intermolecular examples of this new reaction. We anticipate that such studies will ultimately enable the rational incorporation of PdIV-mediated C–H activation into Pd-catalyzed processes.

Supplementary Material

1_si_001
2_si_002
3_si_003

Acknowledgements

We thank the National Science Foundation (CHE-0545909) for support of this work, and N. D. B. thanks the NIH (F31GM089141) for a pre-doctoral fellowship. Dr. Antek Wong-Foy and Dr. Jeff Kampf are gratefully acknowledged for X-ray crystallography, and we acknowledge funding from NSF grant CHE-0840456 for X-ray instrumentation. We are also grateful to Dr. Eugenio Alavarado and Ansis Maleckis for assistance with NMR spectroscopic analysis, and Dr. Dipa Kalyani and Ansis Maleckis for ligand synthesis.

Footnotes

Supporting Information Available: Experimental details and spectroscopic and analytical data for new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

REFERENCES

  • 1.(a) Powers DC, Ritter T. Top. Organomet. Chem. 2011;35:129. doi: 10.1007/978-3-642-17429-2_6. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Xu LM, Li BJ, Yang Z, Shi ZJ. Chem. Soc. Rev. 2010;39:712. doi: 10.1039/b809912j. [DOI] [PubMed] [Google Scholar]; (c) Sehnal P, Taylor RJK, Fairlamb IJS. Chem. Rev. 2010;110:824. doi: 10.1021/cr9003242. [DOI] [PubMed] [Google Scholar]; (d) Deprez NR, Sanford MS. Inorg. Chem. 2007;46:1924. doi: 10.1021/ic0620337. [DOI] [PubMed] [Google Scholar]; (e) Muniz K. Angew. Chem. Int. Ed. 2009;48:9412. doi: 10.1002/anie.200903671. [DOI] [PubMed] [Google Scholar]; (f) Canty AJ. Dalton Trans. 2009;47:10409. doi: 10.1039/b914080h. [DOI] [PubMed] [Google Scholar]
  • 2.For recent examples, see: Zhao XD, Dong VM. Angew. Chem. Int. Ed. 2011;50:932. doi: 10.1002/anie.201005489. Oloo W, Zavalij PY, Zhang J, Khasin E, Vedernikov AN. J. Am. Chem. Soc. 2010;132:14400. doi: 10.1021/ja107185w. Powers DC, Benitez D, Tkatchouk E, Goddard WA, III, Ritter T. J. Am. Chem. Soc. 2010;132:14092. doi: 10.1021/ja1036644. Khusnutdinova JR, Rath NP, Mirica LM. J. Am. Chem. Soc. 2010;132:7303. doi: 10.1021/ja103001g. Shabashov D, Daugulis O. J. Am. Chem. Soc. 2010;132:3965. doi: 10.1021/ja910900p. Furuya T, Benitez D, Tkatchouk E, Strom AE, Tang P, Goddard WA, Ritter T. J. Am. Chem. Soc. 2010;132:3793. doi: 10.1021/ja909371t. Racowski JM, Dick AR, Sanford MS. J. Am. Chem. Soc. 2009;131:10974. doi: 10.1021/ja9014474.
  • 3.(a) Wang X, Leow D, Yu JQ. J. Am. Chem. Soc. 2011;133:13864. doi: 10.1021/ja206572w. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hull KL, Lanni EL, Sanford MS. J. Am. Chem. Soc. 2006;128:14047. doi: 10.1021/ja065718e. [DOI] [PubMed] [Google Scholar]
  • 4.Sibbald PA, Rosewall CF, Swartz RD, Michael FE. J. Am. Chem. Soc. 2009;131:15945. doi: 10.1021/ja906915w. [DOI] [PubMed] [Google Scholar]
  • 5.Pilarski LT, Selander N, Bose D, Szabo KJ. Org. Lett. 2009;11:5518. doi: 10.1021/ol9023369. [DOI] [PubMed] [Google Scholar]
  • 6.Hickman AJ, Sanford MS. ACS Catal. 2011;1:170. [Google Scholar]
  • 7.Kawai H, Kobayshi Y, Oi S, Inoue Y. Chem. Commun. 2008:1464. doi: 10.1039/b717251f. [DOI] [PubMed] [Google Scholar]
  • 8.For intermolecular C–H activation at PtIV centers see: Shul’pin GB, Nizova GV, Nikitaev AT. J. Organomet. Chem. 1984;276:115.
  • 9.For intramolecular C–H activation at PtIV centers, see: Mamtora J, Crosby SH, Newman CP, Clarkson GJ, Rourke JP. Organometallics. 2008;27:5559.
  • 10.For representative reviews on intramolecular C–H activation see: Albercht M. Chem. Rev. 2010;110:576. doi: 10.1021/cr900279a. Dupont J, Consorti CS, Spencer J. Chem. Rev. 2005;105:2527. doi: 10.1021/cr030681r. Brune MI. Angew. Chem. Int. Ed. Engl. 1977;16:73.
  • 11.Use of bidentate sp2 N-donor ligands to stabilize PdIV: Canty AJ. Acc. Chem. Res. 1992;25:83.
  • 12.Use of chloride ligands to stabilize PdIV: McCall AS, Wang H, Desper JM, Kraft S. J. Am. Chem. Soc. 2011;133:1832. doi: 10.1021/ja107342b. Vicente J, Arcas A, Julia-Hernandez F, Bautista D. Chem. Commun. 2010;46:7253. doi: 10.1039/c0cc02660c. Vicente J, Chicote MT, Lagunas MC, Jones PG, Bembenek E. Organometallics. 1994;13:1243. Alsters PJ, Engel PM, Hogerheide MP, Copijn M, Spek AL, van Koten G. Organometallics. 1993;12:1831. Gray LR, Gulliver DJ, Levason W, Webster M. J. Chem. Soc. Dalton Trans. 1983:133. Kukushkin YN, Sedova GN, Vlasova RA. Zh. Neorg. Khim. 1978;23:1977. Uson R, Fornies J, Navarro R. J. Organomet. Chem. 1975;96:307.
  • 13.Use of PhICl2 to oxidize PdII to PdIV: (a) Ref. 12a. Pearson SL, Sanford MS, Arnold P. J. Am. Chem. Soc. 2009;131:13812. doi: 10.1021/ja905713t. Whitfield SR, Sanford MS. J. Am. Chem. Soc. 2007;129:15142. doi: 10.1021/ja077866q. Lagunas MC, Gossage RA, Spek AL, van Koten G. Organometallics. 1998;17:731.
  • 14.(a) Ball ND, Gary JB, Ye Y, Sanford MS. J. Am. Chem. Soc. 2011;133:7577. doi: 10.1021/ja201726q. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Ye Y, Ball ND, Sanford MS. J. Am. Chem. Soc. 2010;132:14682. doi: 10.1021/ja107780w. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Ball ND, Kampf J, Sanford MS. J. Am. Chem. Soc. 2010;132:2878. doi: 10.1021/ja100955x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.When the reaction was conducted at −30 °C, the initial NMR spectrum showed the presence of intermediate 8 along with some of the C–H activation product 5-Cl (ratio 8 : 5-Cl = 3 : 1). The [8] did not change over several hours at −30 °C, and this ratio remained constant over that time. Conversion of 8 to a mixture of 5-Cl and 6 only occurred when the mixture was warmed. These data suggest that the 5-Cl formed initially in the −30 °C experiment is generated by a different, heretofore undetected intermediate. See Supporting Information for a detailed discussion.
  • 16.1H NMR spectroscopic studies of the oxidation of 4-d5 (in which the pendant phenyl ring is deuterated) further confirmed the assignment of the 5 aromatic protons of this ring in intermediate 8.
  • 17.A key remaining question is the stereochemistry about the octahedral PdIV center in 8. We have conducted several experiments to probe this and they provide tentative support for the structure shown in Scheme 3. See Supporting Information (p. S21) for a detailed discussion.
  • 18.An alternative possible route to 10 would involve electrophilic chlorination of the aromatic ring similar to that described in ref. 12a.
  • 19.Notably, similar selectivity was reported in ref. 3, where cyclopalladation at PdIV is proposed as a key step in catalysis.
  • 20.The oxidation of 11 with PhICl2 under otherwise identical conditions provided 12-Cl as the major product with >10 : 1 selectivity. This suggests that site selectivity in C–H activation at PdIV is highly sensitive to the ligand environment at the metal center. More extensive investigations of ligand effects in this system are ongoing.
  • 21.Under analogous conditions (benzene, 4 h, 60 °C), the reaction of 11 with NFTPT resulted in the same 1.7 : 1 ratio as observed in Scheme 4.
  • 22.For examples, see ref. 10 as well as: Kalyani D, Sanford MS. Org. Lett. 2005;7:4149. doi: 10.1021/ol051486x.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001
2_si_002
3_si_003

RESOURCES